Myocardial Protection Clinical Trial
Official title:
Levosimendan Pre-Treatment in Patients Undergoing Coronary Artery Bypass Graft Surgery: a Double-Blind, Single Center, Prospective, Randomized, Placebo-Controlled Trial
The aim of this study is to investigate whether pharmacological pre-treatment with levosimendan reduces intensive care unit (ICU) length of stay in patients undergoing elective myocardial revascularization under cardiopulmonary bypass.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00546390 -
Protection of the Heart With Remote Ischemic Preconditioning During Heart Surgery: A Pilot Study
|
N/A | |
Completed |
NCT01941420 -
Comparison of Blood and Crystalloid Cardioplegia
|
N/A | |
Completed |
NCT01941459 -
Comparison of Blood Cardioplegia and Custodiol
|
N/A | |
Completed |
NCT03859115 -
Effects of TENS on Myocardial Protection in Patients Undergoing AVR
|
N/A | |
Completed |
NCT04231903 -
Myocardial Protection in Minimally Invasive Mitral Valve Surgery
|
||
Completed |
NCT06287372 -
Comparison of Changes in Intra-myocardial Amino Acids During Use of Calafiore and Modified Del Nido Cardioplegia
|
||
Not yet recruiting |
NCT03595111 -
Myocardial Biopsy in Congenital Cardiac Surgery
|
N/A |